医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GC Pharma Lights Up to Celebrate ‘World Hemophilia Day’

2021年04月18日 AM11:09
このエントリーをはてなブックマークに追加


 

YONGIN, South Korea

GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, participates in a campaign to celebrate World Hemophilia Day.

As part of GC Pharma’s continued support of the hemophilia community, the company features this year’s slogan image on a giant exterior media façade of its main campus in Yongin, South Korea.

Started in 1989 by the World Federation of Hemophilia (WFH), in honor of their founder Frank Schnabel’s birthday, World Hemophilia Day is celebrated each year on April 17th and intended to raise awareness of the disease and other bleeding disorders.

This year’s slogan is “Adapting to Change, sustaining care in a new world”. With this slogan, the global bleeding disorders community emphasizes the continuity of treatment for bleeding disorders, including haemophilia, in a world that has turned into Covid-19.

About Hemophilia

Hemophilia is a congenital disorder that causes longer-than-normal bleeding due to absent or deficient clotting factor in the blood. Hemophilia A is more common than hemophilia B; hemophilia A affects about 150,000 people, whereas hemophilia B affects about 30,000 people worldwide. Treatment regimens typically include on-demand and/or regular prophylactic infusions of factor replacement therapy to control or prevent the risk of bleeding. People with hemophilia, working closely with their healthcare professionals, can live healthy lives with proper care and adequate treatment.

About GC Pharma

GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions for more than half a century. Green Cross Corporation updated its corporate brand to GC Pharma in early 2018. Green Cross Corporation remains the company’s registered, legal name.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210417005011/en/

CONTACT

Media Contacts

HyunGoo Kang

gookang@gccorp.com

WooSub Shin

isswoo@gccorp.com

Yelin Jun

yelin@gccorp.com

Hansaem Kim

hs.kim@gccorp.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
  • Exome-Backed Broncus Holding Corporation Launches Hong Kong Public Offering
  • Saladax Biomedical宣布Salvatore J. Salamone博士荣获著名的C.E. Pippenger博士奖
  • IHMA在上海建立微生物学参考实验室,进一步支持全球抗感染产品的发现和开发
  • Rhizen Pharmaceuticals AG宣布,RP7214治疗新冠肺炎患者2期研究进行首例患者给药